Interestingly, nonalcoholic fatty liver disease (NAFLD), a liver disease that has been shown to impact on cardiovascular morbidity, is also associated with an elevated AST/ALT ratio that, in turn, reflects liver fibrosis and predicts long-term complications [19,20]. The gene discussed is GPT; the disease is Hepatic fibrosis.